Nowadays, potential advantages of BIMA grafting are recognized overall in terms of long-term survival1 and by not increasing operative morbidity. One of the major restrictions for extending the use of BIMA grafting is the current impossibility of generalizing the procedure to higher risk patients. These results tend to confirm recent results that promote the use of BIMA grafting in every kind of patients and consequently to confirm the generalization of the procedure, without being afraid of sternal complications. The absence of deep sternal wound infection in our study shows that there is no contraindication of BITA grafting among diabetic patients.
Part of the book: The Current Perspectives on Coronary Artery Bypass Grafting